BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 20965462)

  • 1. Transradial versus transfemoral method of percutaneous coronary revascularization for unprotected left main coronary artery disease: comparison of procedural and late-term outcomes.
    Yang YJ; Kandzari DE; Gao Z; Xu B; Chen JL; Qiao SB; Li JJ; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; Liu HB; Dai J; Chen T; Wang Y; Li W; Gao RL
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1035-42. PubMed ID: 20965462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of procedural and long-term outcomes between transradial and transfemoral approach in one-stage intervention for triple vessel coronary artery disease.
    Dou K; Xu B; Yang Y; Chen J; Qiao S; Wang Y; Li J; Qin X; Yao M; Liu H; Wu Y; Chen J; Yuan J; You S; Gao R
    J Interv Cardiol; 2014 Apr; 27(2):108-16. PubMed ID: 24588842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transradial versus transfemoral method of two-stent implantation for true bifurcation lesions: comparison of immediate and long-term outcomes.
    Gao Z; Xu B; Yang Y; Kandzari DE; Sun Z; Qiao S; Wu Y; Yan H; Yuan J; Chen J; Zhao Y; Gao R
    J Interv Cardiol; 2014 Apr; 27(2):99-107. PubMed ID: 24528337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between one-stent versus two-stent technique for treatment of left main bifurcation lesions: A large single-center data.
    Gao Z; Xu B; Yang Y; Qiao S; Wu Y; Chen T; Xu L; Yuan J; Chen J; Gao RL
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1132-8. PubMed ID: 25614097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between transradial and transfemoral percutaneous coronary intervention in acute ST-elevation myocardial infarction.
    Ibebuogu UN; Cercek B; Makkar R; Dinh H; Kwarteng C; Mirocha J; Hussaini A; Singh S; Dohad S; Shah PK; Khorsandi M; Kar S
    Am J Cardiol; 2012 Nov; 110(9):1262-5. PubMed ID: 22840847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transradial versus transfemoral intervention for the treatment of left main coronary bifurcations: results from the COBIS (COronary BIfurcation Stenting) II Registry.
    Chung S; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Jang Y; Yoon JH; Tahk SJ; Seung KB; Gwon HC
    J Invasive Cardiol; 2015 Jan; 27(1):35-40. PubMed ID: 25589699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term efficacy of abciximab bolus-only compared to abciximab bolus and infusion after transradial coronary stenting.
    Bagur R; Bertrand OF; Rodés-Cabau J; Larose E; Rinfret S; Nguyen CM; Noel B; Larochellière RD; Poirier P; Costerousse O; Roy L
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1010-6. PubMed ID: 19753635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
    Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of provisional side-branch T-stenting for the treatment of unprotected distal left main coronary artery disease.
    De Luca L; Altamura L; Corvo P; De Persio G; Ghini AS; Petrolini A; Aurigemma C; Tomai F
    Catheter Cardiovasc Interv; 2011 May; 77(6):765-72. PubMed ID: 21413124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical outcomes with the use of a modified provisional jailed-balloon stenting technique for the treatment of nonleft main coronary bifurcation lesions.
    Depta JP; Patel Y; Patel JS; Novak E; Yeung M; Zajarias A; Kurz HI; Lasala JM; Bach RG; Singh J
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):E637-46. PubMed ID: 23420654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Operator and institutional experience reduces room-to-balloon times for transradial primary percutaneous coronary intervention.
    Barringhaus KG; Akhter M; Rade JJ; Smith C; Fisher DZ
    J Invasive Cardiol; 2014 Feb; 26(2):80-6. PubMed ID: 24486667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of transradial and transfemoral coronary intervention in octogenarians with acute myocardial infarction.
    Lee HW; Cha KS; Ahn J; Choi JC; Oh JH; Choi JH; Lee HC; Yun E; Jang HY; Choi JH; Hong TJ; Jeong MH; Ahn Y; Chae SC; Kim YJ;
    Int J Cardiol; 2016 Jan; 202():419-24. PubMed ID: 26433163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent).
    Ellis SG; Stone GW; Cox DA; Hermiller J; O'Shaughnessy C; Mann T; Turco M; Caputo R; Bergin PJ; Bowman TS; Baim DS;
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1248-59. PubMed ID: 20129552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
    Onuma Y; Kukreja N; Daemen J; Garcia-Garcia HM; Gonzalo N; Cheng JM; van Twisk PH; van Domburg R; Serruys PW;
    JACC Cardiovasc Interv; 2009 Jul; 2(7):603-10. PubMed ID: 19628181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical and economic analysis of the Endeavor drug-eluting stent versus the Driver bare-metal stent: 4-year results from the ENDEAVOR II trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions).
    Eisenstein EL; Wijns W; Fajadet J; Mauri L; Edwards R; Cowper PA; Kong DF; Anstrom KJ
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1178-87. PubMed ID: 20129543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of transradial and transfemoral approaches for percutaneous coronary intervention in elderly patients based on a propensity score analysis.
    He PY; Yang YJ; Qiao SB; Xu B; Yao M; Wu YJ; Yuan JQ; Chen J; Liu HB; Dai J; Tang XR; Wang Y; Li W; Gao RL
    Angiology; 2015 May; 66(5):448-55. PubMed ID: 24834930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.
    Leon MB; Nikolsky E; Cutlip DE; Mauri L; Liberman H; Wilson H; Patterson J; Moses J; Kandzari DE;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1043-50. PubMed ID: 20965463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transitioning to the radial artery as the preferred access site for cardiac catheterization: an academic medical center experience.
    Turner S; Sacrinty M; Manogue M; Little W; Gandhi S; Kutcher M; Santos R; Applegate R
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):247-57. PubMed ID: 22162430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.